Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) Therapy

Clinical trial NCT02484677 · COMPLETED

Trial details

NCT number: NCT02484677
Sponsor: Assistance Publique Hopitaux De Marseille
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Patients With Head and Neck Cancer (ORL)

Start date: 2015-07-15
Primary completion: 2017-01-25
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.